Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

By HospiMedica International staff writers
Posted on 22 May 2025

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. More...

This group is at an elevated risk for respiratory distress, a major contributor to neonatal morbidity and prolonged hospitalizations. Conventional clinical approaches often rely on a "wait and see" method to determine which infants require intervention. Unfortunately, this approach can lead to higher NICU admissions, delayed treatments, increased healthcare expenses, and added stress for families and infants. Now, an artificial intelligence (AI)-driven lung maturity test (LMT) is poised to close this gap by providing an objective screening tool to help identify newborns who are at risk more promptly.

SIME Diagnostics (London, UK) has developed an innovative platform that includes a point-of-care device and a single-use cartridge designed to quickly analyze routinely collected samples without the need for reagents. The device enables the real-time evaluation of lung biochemistry by measuring key biomarkers—lecithin and sphingomyelin. These biomarkers' ratio reflects surfactant levels, which are crucial for efficient oxygen exchange in developing lungs. By offering clinicians valuable data to guide respiratory support decisions within the first hour of life, the AI platform aids in the early identification of infants needing intervention, reducing unnecessary treatments and minimizing delays. This platform is specifically designed for use in intensive care settings, helping healthcare professionals provide timely and focused respiratory care.

In a recent study involving 207 late-preterm infants (those born at more than 30 weeks' gestation), researchers tested gastric aspirate samples using the point-of-care device from SIME Diagnostics. The results indicated that the LMT successfully assessed biomarkers related to lung maturity, facilitating early identification of infants at risk for respiratory distress. The study concluded that the device accurately predicted which infants would require extended respiratory support and identified those whose need for such support would resolve within six hours. Ongoing studies and clinical assessments aim to refine the device's applications further, potentially extending its use across various hospital settings.

Related Links:
SIME Diagnostics


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Examination & Procedure Light
Vega 80
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.